Lamotrigine Tablet
Product Images NDC 0615-8150

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 0615-8150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 1

Chemical structure diagram of lamotrigine, showing the molecular arrangement including chlorine atoms and nitrogen-containing rings, consistent with the active ingredient lamotrigine.*

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 2

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over approximately 90 weeks. The x-axis represents time in weeks, and the y-axis shows failure probability percentage. The graph includes censoring marks and shows two survival curves labeled 'Placebo' and 'Lamotrigine.'*

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 3

A Kaplan-Meier curve showing failure probability percentage over a period of 80 weeks. Two curves compare Lamotrigine and placebo groups, with the Lamotrigine curve generally lower than the placebo, indicating difference in failure probability over time. The graph includes censored data marks for both groups.*

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 4

Table showing physical descriptions of Lamotrigine tablets in various strengths (25 mg, 50 mg, 100 mg, 150 mg, 200 mg, and 250 mg). Each tablet is white to off-white with one side of the bisect debossed with 'ZC' and a strength-specific number on the other side, ranging from '79' to '91' depending on dosage.*

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 5

This text panel describes two Lamotrigine tablet strengths: 5 mg tablets that are white to off-white, bisected and debossed with 'Z' on one side and '13' on the other; and 25 mg tablets that are white to off-white and debossed with 'Z' and '12' on one side.*

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 6

Lamotrigine Tablets USP 25 mg oral tablet packaging label showing the product name, strength, and dosage form. The label includes multiple small duplicate product labels arranged in a grid, each listing Lamotrigine 25 mg tablets packaged by Vangard Labs, Glasgow, KY. It also displays lot number 7964 and barcode 6838200610. Instructions note storage at 20°-25°C and dispensing in a light-resistant container. The label states Rx Only and indicates the product is for institutional use.*

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 7

Lamotrigine Tablets USP 100 mg oral tablets label by NCS HealthCare of KY, LLC dba Vangard Labs. The label includes product name, strength (100 mg), quantity of 30 tablets, lot number 7975, and storage instructions to keep at 20°-25°C in a light-resistant container. It is manufactured by Cadila for Zydus with NDC 68382-008-10 and includes multiple small barcode labels for individual units.*

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 8

Label for Lamotrigine Tablets USP 150 mg in oral tablet form. The label includes dosage strength (150 mg), manufacturer information (NCS HealthCare of KY, LLC dba Vangard Labs), lot number, and barcode. It is indicated for institutional use with instructions for storage and handling.*

FDA Label Image

Lamotrigine 25mg100mg150mg200mg Cadila For Zydus 9

Lamotrigine Tabs USP 200 mg oral tablets packaging label showing multiple individual dose labels with barcodes, lot number 8267, and expiration date fields. The label is from NCS HealthCare of KY, LLC dba Vangard Labs and manufactured by Cadila for Zydus. It includes storage instructions to store at 20°-25°C and a caution to verify the product dispensed. The packaging is marked for institutional use only and includes a calendar section for dose administration tracking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.